LY4052031
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY4052031, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]